Physician profile
Lindy E Harrell
NPI 1164458139
$1,080.16
in general payments reported to CMS, 2019-2025
21 companies · $56.63 in 2025
The $56.63 reported for 2025 was less than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $85.41 · 2020: $150 · 2021: $308 · 2022: $185 · 2023: $174 · 2024: $122 · 2025: $56.63.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $352.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $352.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $304.42 | 2021-2025 | |
| Indivior INC. | $95.09 | 2020-2025 | Sublocade |
| Novo Nordisk INC | $87.32 | 2019-2023 | Ozempic, Rybelsus |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $78.11 | 2021-2023 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $64.70 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $55.58 | 2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $43.65 | 2020-2021 | |
| Amgen INC. | $43.16 | 2020-2021 | |
| Sanofi-Aventis U.S. LLC | $41.58 | 2020-2021 | |
| Biohaven Pharmaceutical Holding Company Ltd. | $38.05 | 2022 | |
| Lilly USA, LLC | $32.93 | 2021-2024 | Jardiance, Zepbound |
| Astellas Pharma US INC | $31.98 | 2021 | |
| Pear Therapeutics (US), INC. | $26.78 | 2021 | |
| Alkermes, INC. | $21.00 | 2019 | |
| Astrazeneca Pharmaceuticals Lp | $20.75 | 2021 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ardelyx, INC. | $19.04 | 2025 | Ibsrela |
| Otsuka America Pharmaceutical, INC. | $18.47 | 2020 | |
| Biohaven Pharmaceuticals, INC. | $16.60 | 2021 | |
| Upsher-Smith Laboratories LLC | $16.06 | 2019 | |
| Dexcom, INC. | $13.26 | 2021 | |
| Scilex Pharmaceuticals INC. | $11.63 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lindy Harrell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.